These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11782452)

  • 21. Organogenesis and angiogenin.
    Vallee BL; Riordan JF
    Cell Mol Life Sci; 1997 Oct; 53(10):803-15. PubMed ID: 9413551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actin is a binding protein for angiogenin.
    Hu GF; Strydom DJ; Fett JW; Riordan JF; Vallee BL
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1217-21. PubMed ID: 7679494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-actinin-2, a cytoskeletal protein, binds to angiogenin.
    Hu H; Gao X; Sun Y; Zhou J; Yang M; Xu Z
    Biochem Biophys Res Commun; 2005 Apr; 329(2):661-7. PubMed ID: 15737636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited proteolysis of angiogenin by elastase is regulated by plasminogen.
    Hu GF
    J Protein Chem; 1997 Oct; 16(7):669-79. PubMed ID: 9330225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
    Ries M; Zenker M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
    Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
    Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen receptors in the mediation of pericellular proteolysis.
    Plow EF; Miles LA
    Cell Differ Dev; 1990 Dec; 32(3):293-8. PubMed ID: 1965955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
    Nilsson T; Sjöholm I; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
    Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug.
    de Groot FM; Broxterman HJ; Adams HP; van Vliet A; Tesser GI; Elderkamp YW; Schraa AJ; Kok RJ; Molema G; Pinedo HM; Scheeren HW
    Mol Cancer Ther; 2002 Sep; 1(11):901-11. PubMed ID: 12481411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in antiplasmin and plasmin activities during extreme hemodilution and open heart surgery in dogs.
    Aasen AO; Gallimore MJ; Lilleaasen P; Lyngaas K; Larsbraaten M; Amundsen E
    Eur Surg Res; 1979; 11(3):145-53. PubMed ID: 159822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics.
    Roiz L; Smirnoff P; Bar-Eli M; Schwartz B; Shoseyov O
    Cancer; 2006 May; 106(10):2295-308. PubMed ID: 16586499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-2-plasmin inhibitor comprises a single domain.
    Magnotti RA; Halsall HB
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1062-70. PubMed ID: 2945559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmin/alpha2-antiplasmin complexes (PAP) in lung cancer patients: effects of radiotherapy.
    Uszyński M; Ziółkowska E; Zekanowska E; Uszyński W
    Thromb Haemost; 2002 Jul; 88(1):169-70. PubMed ID: 12152666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.